Stuart Rich

Q: What Schools Are Affiliated With Stuart Rich

Stuart Rich is affiliated with the following schools: University of California, Berkeley, Northwestern University, University of Illinois College of Medicine, University of Chicago, Columbia University, Washington University in St. Louis, McGill University, Imperial College London, Stanford University, Johns Hopkins University, Rush University, University of Illinois Chicago, Harvard University

Stuart Rich's AcademicInfluence.com Rankings

Stuart Rich

Engineering

#5139

World Rank

#6383

Historical Rank

Electrical Engineering

#1394

World Rank

#1487

Historical Rank

engineering Degrees

Stuart Rich

Computer Science

#6593

World Rank

#6951

Historical Rank

Computational Linguistics

#1173

World Rank

#1187

Historical Rank

Machine Learning

#2196

World Rank

#2224

Historical Rank

Artificial Intelligence

#2463

World Rank

#2504

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

Stuart Rich's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering University of California, Berkeley
Bachelors Computer Engineering University of California, Berkeley

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2026

Why Is Stuart Rich Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stuart Rich's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. (1996) (2445)
Primary pulmonary hypertension. A national prospective study. (1987) (2023)
The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. (1992) (1475)
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. (2002) (1365)
Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy (2002) (1225)
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease (2000) (1084)
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. (1996) (850)
Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. (1998) (674)
Beraprost therapy for pulmonary arterial hypertension. (2003) (608)
Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. (1996) (522)
Clinical classification of pulmonary hypertension. (2001) (508)
Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. (1989) (455)
A USA-based registry for pulmonary arterial hypertension: 1982–2006 (2007) (438)
Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. (2001) (427)
International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). (1998) (392)
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation (2009) (388)
High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. (1987) (378)
Pulmonary arterial hypertension: epidemiology and registries. (2013) (376)
Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". (2000) (375)
The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. (1998) (363)
Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. (2008) (354)
Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice. (2011) (317)
Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension (1997) (313)
Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. (1995) (305)
Clinical Characteristics of Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction (2011) (279)
Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study. (2002) (251)
Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. (2004) (238)
Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension (2003) (229)
Endothelin Receptor Blockers in Cardiovascular Disease (2003) (213)
Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty: SCOUT Trial 30-Day Results. (2017) (210)
Compassionate Use of Continuous Prostacyclin in the Management of Secondary Pulmonary Hypertension: A Case Series (1999) (205)
Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension (2012) (192)
Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. (2000) (189)
The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. (1999) (186)
Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report. (2014) (181)
Doppler echocardiography assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension (1986) (178)
Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. (1995) (178)
Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. (2008) (171)
Utility of electron beam computed tomography to stratify patients presenting to the emergency room with chest pain. (1999) (159)
Antinuclear antibodies in primary pulmonary hypertension. (1986) (154)
Reproducibility of the measurement of coronary calcium with ultrafast computed tomography. (1995) (152)
Determination of left ventricular ejection fraction by visual estimation during real-time two-dimensional echocardiography. (1982) (151)
Primary pulmonary hypertension (1988) (149)
Relationship of BMPR2 Mutations to Vasoreactivity in Pulmonary Arterial Hypertension (2006) (148)
Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. (1983) (143)
Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. (1990) (136)
Appetite-suppressant drugs and the risk of primary pulmonary hypertension (1997) (135)
Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension. (1985) (129)
Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. (2011) (123)
Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension. (2010) (123)
Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed. (2010) (120)
Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure (1989) (117)
Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. (1992) (114)
Influence of age and gender on the presence of coronary calcium detected by ultrafast computed tomography. (1995) (112)
The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. (1985) (111)
Comparison of the effects of adenosine and nifedipine in pulmonary hypertension. (1992) (111)
Association of Serum Creatinine With Abnormal Hemodynamics and Mortality in Pulmonary Arterial Hypertension (2008) (110)
Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension. (1984) (108)
Pulmonary hypertension from chronic pulmonary thromboembolism. (1988) (107)
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. (1997) (103)
Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension. (2005) (99)
Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. (1997) (97)
Clinical Diagnosis of Pulmonary Hypertension (2014) (94)
Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension. (1995) (92)
Uncertainties in the Diagnosis and Treatment of Pulmonary Arterial Hypertension (2008) (92)
Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension. (1995) (90)
Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. (1983) (89)
Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes. (1986) (89)
Temporal trends and drug exposures in pulmonary hypertension: an American experience. (2006) (89)
Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension. (2004) (86)
The current treatment of pulmonary arterial hypertension: time to redefine success. (2006) (86)
Clinical assessment of heart chamber size and valve motion during cardiopulmonary resuscitation by two-dimensional echocardiography. (1981) (85)
High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing. (1991) (85)
Doppler echocardiographic assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension. (1986) (82)
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. (2002) (80)
The effects of phenylephrine on right ventricular performance in patients with pulmonary hypertension. (1990) (77)
Contemporary Survival in Patients with Pulmonary Arterial Hypertension: A Reappraisal of the National Institutes of Health Risk Stratification Equation (2009) (74)
Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension. (2008) (72)
Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension (2015) (71)
[Pulmonary arterial hypertension: epidemiology and registries]. (2014) (70)
Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension. (2016) (68)
Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension. (2010) (67)
The prevalence and significance of a patent foramen ovale in pulmonary hypertension. (1993) (63)
Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women. (2003) (63)
Pulmonary hypertension: a cellular basis for understanding the pathophysiology and treatment. (1989) (61)
Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. (2017) (60)
Increased prevalence of significant coronary artery calcification in patients with diabetes. (2001) (59)
Noninvasive cardiac output measurements in patients with pulmonary hypertension (2012) (58)
Stenting to reverse left ventricular ischemia due to left main coronary artery compression in primary pulmonary hypertension. (2001) (55)
Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy. (2002) (54)
Right ventricular assist device in end-stage pulmonary arterial hypertension: insights from a computational model of the cardiovascular system. (2012) (53)
Tricuspid regurgitation progression and regression in pulmonary arterial hypertension: implications for right ventricular and tricuspid valve apparatus geometry and patients outcome (2017) (53)
Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment. (1982) (53)
The International Primary Pulmonary Hypertension Study (IPPHS). (1994) (51)
Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension. (1983) (51)
Clinical insights into the pathogenesis of primary pulmonary hypertension. (1998) (50)
Development of Atherosclerosis in Genetically Hyperlipidemic Rabbits during Chronic Fish‐oil Ingestion (1989) (47)
Thromboxane synthetase inhibition in primary pulmonary hypertension. (1987) (46)
The WHO classification of pulmonary hypertension: A case-based imaging compendium (2012) (45)
Right ventricular adaptation and maladaptation in chronic pulmonary arterial hypertension. (2012) (45)
Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension. (1993) (44)
Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension. (2009) (43)
Value of Exercise Treadmill Testing in the Risk Stratification of Patients With Pulmonary Hypertension (2009) (43)
Reproducibility of left ventricular myocardial volume and mass measurements by ultrafast computed tomography. (1991) (43)
Detection of subclinical cardiovascular disease: the emerging role of electron beam computed tomography. (2002) (42)
Determination of left ventricular ejection fraction using ultrafast computed tomography. (1986) (42)
Severe pulmonary hypertension associated with COPD. (2000) (40)
Analysis of regional pulmonary enhancement in dogs by ultrafast computed tomography. (1992) (40)
Textbook of Pulmonary Vascular Disease (2009) (39)
Persistence of complex vascular lesions despite prolonged prostacyclin therapy of pulmonary arterial hypertension (2012) (36)
The 6-minute walk test as a primary endpoint in clinical trials for pulmonary hypertension. (2012) (35)
The prevalence of pulmonary hypertension in the United States. Adult population estimates obtained from measurements of chest roentgenograms from the NHANES II Survey. (1989) (35)
A Double‐Blind Comparison of Lisinopril with Captopril in Patients with Symptomatic Congestive Heart Failure (1987) (35)
Medical treatment of primary pulmonary hypertension: a bridge to transplantation? (1995) (33)
Timing of single lung transplantation for primary pulmonary hypertension. (1994) (32)
Survival in Patients with Primary Pulmonary Hypertension (2020) (32)
The value of approved therapies for pulmonary arterial hypertension. (2007) (30)
Successful management of labor and delivery in primary pulmonary hypertension. (1993) (29)
Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial. (2021) (29)
26. Pulmonary Hypertension Associated with Hepatic Cirrhosis (1990) (26)
Pulmonary hypertension--advances in medical and surgical interventions. (1998) (26)
Exercise ultrafast computed tomography for the detection of coronary artery disease. (1989) (24)
Primary pulmonary hypertension. Current update. (1984) (23)
Computed tomography of the heart and great vessels: present and future. (1984) (22)
Familial pulmonary hypertension in association with an abnormal hemoglobin. Insights into the pathogenesis of primary pulmonary hypertension. (1991) (22)
Relation between hormone replacement therapy in women and coronary artery disease estimated by electron beam tomography. (1997) (22)
Plasma von Willebrand factor as a predictor of survival in pulmonary arterial hypertension associated with congenital heart disease. (2011) (21)
EFFICACY AND SAFETY OF CHRONIC SUBCUTANEOUS INFUSION UT-15 IN PULMONARY ARTERIAL HYPERTENSION (PAH) (ABSTRACT 477) (2000) (20)
Comparison of survival in patients with pulmonary hypertension associated with fenfluramine to patients with primary pulmonary hypertension. (2003) (20)
Matrix metalloproteinases in the urine of patients with pulmonary arterial hypertension. (2005) (20)
The Effects of Vasodilators in Pulmonary Hypertension: Pulmonary Vascular or Peripheral Vascular? (2009) (20)
Development of nonspecific interstitial pneumonitis associated with long-term treatment of primary pulmonary hypertension with prostacyclin. (1999) (18)
Pulmonary hypertension: the unaddressed global health burden. (2018) (18)
Short-term effectiveness of nifedipine in secondary pulmonary hypertension. (1993) (18)
The potential role for ultrafast cardiac computed tomography in patients with stroke. (1989) (17)
Erratum: Beraprost therapy for pulmonary arterial hypertension (Journal of the American College of Cardiology (2003) 41 (2119-2125)) (2003) (16)
The medical treatment of primary pulmonary hypertension. Proven and promising strategies. (1994) (15)
Targeting pulmonary vascular disease to improve global health: pulmonary vascular disease: the global perspective. (2010) (15)
Verapamil infusions in the treatment of atrial tachyarrhythmias (1986) (15)
Evaluation Of Noninvasively Measured Cardiac Output In Patients With Pulmonary Hypertension (2011) (13)
International Primary Pulmonary Hypertension Study. (1994) (13)
Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week. (2022) (12)
Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group. (1989) (12)
M-mode echocardiography in left bundle branch block: significance of frontal plane QRS axis. (1982) (11)
The role of thrombosis in pulmonary hypertension. (1993) (11)
Are anticoagulants still indicated in pulmonary arterial hypertension? (2018) (10)
A New Classification of Pulmonary Hypertension (2002) (10)
The use of a durable right ventricular assist device for isolated right ventricular failure due to combined pre- and postcapillary pulmonary hypertension (2019) (9)
Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action from the HELP Trial. (2021) (9)
Severe pulmonary hypertension: critical care clinics. (2001) (9)
Future of clinical trials for pulmonary hypertension. (2011) (9)
Serum nifedipine concentrations and response of patients with pulmonary hypertension. (1996) (8)
A rule for the early detection of chronic changes in cystic fibrosis patient status. (1988) (8)
Prostacyclin and Primary Pulmonary Hypertension (1994) (7)
Pulmonary Hypertension The Effects of Chronic Prostacyclin Therapy on Cardiac Output and Symptoms in Primary Pulmonary Hypertension (2016) (7)
Two dimensional echocardiography of the heart during cardiopulmonary resuscitation in man (1981) (7)
Acceptance of Transcutaneous Nitroglycerin Patches by Patients with Angina Pectoris (1986) (7)
Relative adrenal insufficiency in severe congestive heart failure with preserved systolic function: a case report. (2007) (7)
Pulmonary endarterectomy surgery--a technically demanding cure for WHO Group IV Pulmonary Hypertension: requirements for centres of excellence and availability in Canada. (2011) (7)
Lung transplantation for pulmonary hypertension: patient selection and maintenance therapy while awaiting transplantation. (1998) (6)
Pulmonary hypertension: Preface (2001) (6)
Stephen Archer and Stuart Rich ' ' Work in Progress ' ' Primary Pulmonary Hypertension : A Vascular Biology and Translational Research (2000) (6)
Automated morphologic evaluation of pulmonary arteries in primary pulmonary hypertension. (1986) (6)
Pulmonary hypertension. (2004) (6)
Primary pulmonary hypertension: recent advances. (1986) (6)
Levosimendan‐induced venodilation is mediated by opening of potassium channels (2021) (6)
Calcium channel blockers for the treatment of primary pulmonary hypertension (1995) (5)
Calcium Channel Blocker Therapy: When a Drug Works, it Works. When it Doesn't, it Doesn't (2017) (5)
SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN THE CURRENT ERA: VALIDATION OF THE NATIONAL INSTITUTE OF HEALTH (NIH) RISK STRATIFICATION EQUATION (2007) (4)
What is pulmonary arterial hypertension? (2012) (4)
800-2 Five Year Changes in Coronary Calcification by Ultrafast Computed Tomography (1995) (3)
Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study (2021) (3)
Cardiac catheterization in pulmonary hypertension: doing it right, with a catheter on the left. (2020) (3)
Medical & surgical approaches to pulmonary hypertension. (1997) (3)
The pulmonary hypertension academic research consortium (2013) (3)
How do we explain unexplained pulmonary hypertension in the elderly? (2007) (3)
Primary pulmonary hypertension: modes of diagnosis and aggressive treatment with vasodilators. (1990) (3)
Dual-Energy Computed Tomography as an Alternative Noninvasive Study for Evaluation of Chronic Thromboembolic Pulmonary Hypertension Postoperatively. (2020) (2)
33. NIH Registry on Primary Pulmonary Hypertension: Baseline Characteristics of the Patients Enrolled (1990) (2)
The Pericardial Effusion Pattern on Phase Images (1984) (2)
Radionuclide angiography in patients with tricuspid insufficiency (1982) (2)
Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety (2022) (2)
ONE YEAR EXPERIENCE WITH INTRAVENOUS TREPROSTINIL IN PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENTS (2005) (2)
The role of late gadolinium enhancement of the right ventricular insertion point predicts survival in patients with pulmonary hypertension (2011) (2)
Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases (2021) (2)
Implications of Spontaneous Hemodynamic Variability in Primary Pulmonary-Hypertension (1982) (2)
Captopril for primary pulmonary hypertension: The problem of variability in assessing chronic drug therapy (1982) (2)
OUTCOMES OF PULMONARY HYPERTENSION ASSOCIATED WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (2012) (1)
PULMONARY VASOREACTIVITY TESTING WITH ADENOSINE PREDICTS LONG TERM HEMODYNAMIC RESPONSE TO PROSTACYCLIN MONOTHERAPY, AND PROSTACYCLIN AND PHOSPHODIESTERASE-5 INHIBITOR COMBINATION THERAPY IN PULMONARY ARTERIAL HYPERTENSION (2018) (1)
The importance of sex in pulmonary hypertension. (2012) (1)
Should patients with pulmonary hypertension and increased pulmonary resistance be treated with vasodilators? (1990) (1)
Left Ventricular Diastolic Heart Function and Pulmonary Hypertension (2011) (1)
Vasodilator therapy for pulmonary hypertension. (1980) (1)
Levosimendan Improves Hemodynamics And Submaximal Exercise Capacity In Ph-hfpef: Primary Results From The Help-ph-hfpef Multicenter Randomized Controlled Trial (2020) (1)
Epidemiologic and Clinical Characteristics of Primary Pulmonary Hypertension (1987) (1)
Associated With Connective Tissue Disease Treprostinil, a Prostacyclin Analogue, in Pulmonary Arterial Hypertension (2006) (1)
A reassessment of the acute hemodynamic effects of vasodilators in primary pulmonary hypertension (1981) (1)
Abstract 15294: 24-hour Levosimendan Infusion Decreases Biventricular Filling Pressures and Increases Cardiac Output at Rest and Exercise in PH-HFpEF (2020) (1)
Doppler Echocardiographic Estimates of Pulmonary Artery Systolic Pressure In Patients With Pulmonary Hypertension Are Innacurate (2010) (1)
The Right Ventricle (2012) (1)
Novel shunt modification with an adjustable stent‐embedded “fenestrated” septal occluder in a patient with pulmonary hypertension (2019) (1)
Comprar Textbook Of Pulmonary Vascular Disease | Jason X.-J. Yuan | 9780387874289 | Springer (2011) (0)
Keynote Lecture : Progress in the Pathophysiology and Treatment of Pulmonary Hypertension (2003) (0)
Calcium Channel Blockers in the Treatment of Pulmonary Arterial Hypertension (2011) (0)
Lung Transplantation: Primary pulmonary hypertension: pathophysiology and therapy (2003) (0)
Abstract 2300: Selective Serotonin Reuptake Inhibitor Use is Associated with Decreased Mortality in Pulmonary Hypertension (2007) (0)
LATE GADOLINIUM ENHANCEMENT OF THE RIGHT VENTRICULAR INSERTION POINT PREDICTS SURVIVAL IN PATIENTS WITH PULMONARY HYPERTENSION (2011) (0)
Characteristics of Patients with Pulmonary Hypertension Associated with Left-Sided Heart Failure with Preserved Ejection Fraction. (2009) (0)
International primary pulmonary hypertension study [1] (1994) (0)
CORONARY ARTERY CALCIFICATION IS ASSOCIATED WITH VASCULAR ENDOTHELIAL DYSFUNCTION (1999) (0)
Never Wavering From a Long Commitment to a Cure for PH, Stuart Rich, MD, Aims to Stop the Disease in Its Tracks (2005) (0)
Sildenafil citrate therapy for pulmonary arterial hypertension (vol 353, pg 2148, 2005) (2006) (0)
Ultrafast computed tomography: A new method for the evaluation of hypertrophic cardiomyopathy (1987) (0)
Meeting the Challenge of Surgery and Pulmonary Hypertension: How to Manage the “Hemodynamic Environment” to Optimize Outcomes (2007) (0)
Lung transplantation for pulmonary hypertension: patient selection and maintenance therapy while awaiting transplantation (1998) (0)
Recent Advances in Pulmonary Hypertension (2014) (0)
Primary pulmonary hypertension: Can we meet the challenge? (1985) (0)
The Effect of Vasodilators on Survival in Primary Pulmonary-Hypertension (1983) (0)
Treatment of pulmonary arterial hypertension associated with congenital heart disease with intravenous epoprostenol: impact of therapy on timing of transplantation (2002) (0)
Altered ionized magnesium and calcium in patients with primary pulmonary hypertension (1996) (0)
Noninvasive Measurement Of Cardiac Output During Exercise In Patients With Pulmonary Hypertension (2012) (0)
SUCCESS WITH CALCIUM-CHANNEL BLOCKERS IN A PATIENT WHO FAILED BOSENTAN THERAPY FOR IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION (2006) (0)
Role of Riociguat in the Treatment of Pulmonary Hypertension (2014) (0)
35. Mortality Follow-Up of Primary Pulmonary Hypertension (1990) (0)
The Effect of Vasodilator Therapy on Clinical Outcome in Primary Pulmonary-Hypertension (1983) (0)
437: CMR Late Gadolinium Enhancement of the Right Ventricular Insertion Point in Pulmonary Arterial Hypertension (2010) (0)
Sildenafil And Atorvastatin Added To Bosentan As Therapy For Pulmonary Hypertension (2005) (0)
Communications to the EditorSitaxsentan in Pulmonary Arterial Hypertension (2003) (0)
EXPRESS: Prevalence, Incidence, and Survival of Pulmonary Arterial Hypertension: A Systematic Review for the Global Burden of Disease 2020 Study (2021) (0)
Filling in Patients With Right Ventricular Pressure Overload Due to Primary Pulmonary Hypertension (2010) (0)
Characteristics of Survival in Primary Pulmonary-Hypertension (1982) (0)
Prediction of Mortality in Pulmonary Embolism Based on Left Atrial Volume Measurements: Do Indexed Values Matter? (2016) (0)
Angioscopy and chronic pulmonary arterial obstruction. (1986) (0)
Pulmonary hypertension and late gadolinium enhancement of the right ventricular insertion point and its clinical implications (2010) (0)
Coronary artery calcification screening to rule out acute myocardial infarction prior to hospital admission (1996) (0)
Systemic review of trials using vasodilators in pulmonary arterial hypertension: why a new approac is needed (2010) (0)
TheShort-term Effects ofDigoxin in Patients WithRight Ventricular Dysfunction FromPulmonary Hypertension* (2015) (0)
Abstract 1634: A New Risk-Estimation Equation for Predicting Survival in Patients with Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension (2008) (0)
The Cellular Basis of the Pathophysiology and Treatment of Pulmonary Hypertension (1996) (0)
Prostacyclin for Secondary Pulmonary Hypertension (2000) (0)
Incidence and Prognostic Value of Early Repolarization Pattern in the 12-Lead Electrocardiogram (2011) (0)
The Transition From Chronic Intravenous To Oral Levosimendan Is Safe And Effective In Patients With Pulmonary Hypertension With Heart Failure And Preserved Ejection Fraction (2023) (0)
30 DAY RESULTS OF THE SCOUT I STUDY IN PATIENTS WITH SEVERE TRICUSPID REGURGITATION (TR) (2018) (0)
Diagnosis and Assessment of Non-Pulmonary Arterial Hypertension Masquerading as Idiopathic Pulmonary Arterial Hypertension: Diastolic Heart Failure - Evaluation and Interactions (2008) (0)
Future Directions: An Expert Panel Explores the Challenge of Halting Progression and Reversing the Pathology of PAH (2003) (0)
The Use of Calcium Channel Blockers for the Treatment of Primary Pulmonary Hypertension (1990) (0)
Disease: The Global Perspective Improve Global Health : Pulmonary Vascular Targeting Pulmonary Vascular Disease To (2010) (0)
Correlations between basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), and clinical features of pulmonary arterial hypertension (PAH) (2002) (0)
Classification of left ventricular hypertrophies (LVH) based on discriminant analysis of time activity curve of equilibrium gated studies (1985) (0)
Issues facing the conduct of clinical trials in pulmonary hypertension on a global scale (2009) (0)
ONE-YEAR CHANGES IN RIGHT VENTRICULAR STRAIN FOLLOWING PULMONARY THROMBOENDARTERECTOMY IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020) (0)
ThePrevalence andSignificance ofa PatentForamenOvalein Pulmonary (2015) (0)
linical Classification of Pulmonary Hypertension (2016) (0)
Calcium Channel Blockers in the Treatment of Pulmonary Hypertension (2016) (0)
Unexplained pulmonary hypertension in elderly patients. Editorial (2007) (0)
What constitutes a beneficial response to vasodilators in pulmonary hypertension (1982) (0)
Can primary pulmonary hypertension be treated effectively (1994) (0)
New diastolic filling parameters for evaluation of left ventricular hypertrophies by equilibrium gated studies (1984) (0)
Clinical Insights IntothePathogenesis ofPrimary Pulmonary Hypertension (2017) (0)
THE CELLULAR BASIS OF THE PAmOPHYSIOLOGY AND TREATMENT OF PULMONARY HYPERTENSION (1996) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stuart Rich?

Stuart Rich is affiliated with the following schools:

Stuart Rich's Academic­Influence.com Rankings

Stuart Rich's Degrees

Similar Degrees You Can Earn

Why Is Stuart Rich Influential?

Stuart Rich's Published Works

Published Works

What Schools Are Affiliated With Stuart Rich?

Stuart Rich's AcademicInfluence.com Rankings